Aster DM Quality Care (ASTERDM) investor relations material

Executive summary

• Merger effective July 1, 2026, forming a top 3 hospital chain in India with 39 hospitals and 10,559 operational beds, executed with zero operational friction and strong cultural integration.

• Unaudited consolidated and standalone financial results for the quarter ended 30 June 2026 were reviewed and approved, with auditors expressing an unmodified review conclusion.

• The company completed a merger with Quality Care India Limited, effective 1 July 2026, and changed its name accordingly.

• Combined entity demonstrates strong YoY revenue growth, operational leverage, and improved margins, driven by increased patient volumes and specialty mix.

• Strategic rationale includes scale, enhanced metrics, synergies, diversification, growth potential, and backing by Blackstone.

Financial highlights

• Q1FY27 revenue grew 20% YoY to INR 2,597 Cr; operating EBITDA up 30% YoY to INR 576 Cr; EBITDA margin improved by 170 bps to 22.2%.

• Consolidated revenue from operations for the quarter was INR 1,310.68 crores, up from INR 1,077.87 crores year-over-year.

• Consolidated net profit for the quarter was INR 29.28 crores, compared to INR 93.56 crores in the same quarter last year.

• Net debt for the merged entity stands at INR 1,162 Cr.

• Exceptional items related to merger costs amounted to INR 114.38 crores (consolidated) and INR 109.79 crores (standalone).

Outlook and guidance

• Planned expansion to add 4,179 beds, targeting a total of 15,077 beds by FY30 and beyond, with 53% in existing and 47% in new facilities.

• Synergies expected to deliver 10-15% EBITDA uplift through cost optimization, IT integration, and operational efficiencies.

• The company continues to invest in subsidiaries and associates, indicating ongoing expansion and strategic growth.